CMECME
US • —
$220.83
P/E
18.67
PEG
1.07
FCF Yield
—
Rev Growth YoY
+24.6% YoY
Gross Margin
96.0%
Health Score
8/10
D/E Ratio
0.12
Confidence
LOW
Business Snapshot
CME Group operates financial marketplaces, primarily offering trading in derivatives such as futures and options across interest rates, equity indexes, foreign exchange, and commodities. The company functions as a central counterparty clearing house, providing risk management services to market participants globally. CME holds a dominant competitive position as the world's largest derivatives exchange, benefiting from deep liquidity network effects and a regulatory-advantaged clearing business. Defining characteristics include its near-monopoly position in US treasury futures and a highly scalable electronic trading platform that generates strong incremental margins on volume growth.
Financial Health
CME Group demonstrates exceptional profitability with a gross margin of 96.0% and a net margin of 33.7%, though margin trajectory versus the prior year cannot be assessed from the data. The balance sheet is conservative, with a debt/equity ratio of just 0.12x and a current ratio of 1.03x, indicating minimal leverage and adequate short-term liquidity coverage...
Risk Assessment
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- EARNINGS QUALITY — Out of 4 recent quarters, only 2 beat estimates, indicating average earnings surprise performance and mixed guidance credibility.
- VALUATION DIVERGENCE — DCF fair value estimates are unavailable due to absent free cash flow data, limiting the ability to assess intrinsic value with a fundamental model.
- INSIDER — Insiders have been net sellers over the last 90 days with 2 buys versus 5 sells, a signal that may indicate caution from those closest to the business.
- 52-WEEK POSITION — The 52-week high and low prices are unavailable, preventing an assessment of the current price's position within the historical trading range....
CME Group demonstrates exceptional profitability with a gross margin of 96.0% and a net margin of 33.7%, though margin trajectory versus the prior year cannot be assessed from the data. The balance sheet is conservative, with a debt/equity ratio of just 0.12x and a current ratio of 1.03x, indicating minimal leverage and adequate short-term liquidity coverage. Free cash flow data is unavailable in the payload, preventing a direct assessment of cash generation or yield. Overall, the company's high margins and low leverage suggest capacity for sustained dividends and reinvestment, though the thin current ratio warrants monitoring of liquidity under stress.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - EARNINGS QUALITY — Out of 4 recent quarters, only 2 beat estimates, indicating average earnings surprise performance and mixed guidance credibility. - VALUATION DIVERGENCE — DCF fair value estimates are unavailable due to absent free cash flow data, limiting the ability to assess intrinsic value with a fundamental model. - INSIDER — Insiders have been net sellers over the last 90 days with 2 buys versus 5 sells, a signal that may indicate caution from those closest to the business. - 52-WEEK POSITION — The 52-week high and low prices are unavailable, preventing an assessment of the current price's position within the historical trading range.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives